The Eijkman-Oxford Clinical Research Unit (EOCRU) operates as a fully integrated segment of its Indonesian partner and host, the Eijkman Institute of Molecular Biology (EIMB) in Jakarta, Indonesia. In response to growing commitments to the conduct of clinical trials, EOCRU has also partners with the University of Indonesia (FKUI). This tri-partite partnership means that EOCRU is ideally positioned for realization of its “bench to bedside” research vision.

The vision of EOCRU is to facilitate the creation of a clinical research capacity within the EIMB and on the campus of FKUI leveraging state-of-the-art clinical/medical facilities at FKUI in managing patients in research and trials, and capitalizing the state-of-the-art biotechnological/scientific facilities at EIMB for maximum impact on human health, particularly the health of Indonesians.